Stockreport

Neumora Therapeutics (NMRA) Positioned to Capitalize on Blockbuster Opportunity [Yahoo! Finance]

Neumora Therapeutics, Inc.  (NMRA) 
PDF On February 17, Myles Minter from William Blair upgraded his rating on Neumora Therapeutics Inc. (NASDAQ:NMRA) from Market Perform to Outperform. The analyst also share [Read more]